| Overall | Active | Remission/LDA | p Value |
---|---|---|---|---|
Patient characteristics | ||||
 No. of patients | 35 | 15 | 20 | N/A |
 Sex (males/females) | 16/19 | 7/8 | 9/11 | ns |
 Age, years (mean + range) | 54 (20–78) | 59 (20–73) | 50 (28–78) | ns |
 Years since diagnosis (median + IQR) | 5 (1–12) | 3 (1–12) | 7 (1.3–12.8) | ns |
Disease activity parameters | ||||
 BVAS (median + IQR) |  | 8 (5–10) | 0 (0–0) | < 0.0001 |
 Physician VAS (median + IQR) |  | 6 (2–8) | 0 (0–0.5) | < 0.0001 |
 CRP (mg/L) (median + IQR) |  | 30.9 (6.5–70.7) | 2.5 (1.9–8.7) | < 0.01 |
 ESR (mm/h) (median + IQR) |  | 20.5 (5–38) | 5 (5–10) | < 0.05 |
 Prednisolone (mg/d) (median + IQR) |  | 7.5 (5–15) | 5.8 (0.3–13.8) | ns |
 PR3-ANCA (kIU/L) (median + IQR) |  | 124.6 (4.2–409) | 16 (2.4–80.8) | ns |